Hearing at what Cost? The Slippery Slope of Commodifying Hearing Devices
Madison Cain
ABSTRACT
Recently the hearing aid industry has been rapidly propelled to the national stage following the introduction of new regulations allowing over the-counter hearings aids to be provided directly to consumers. Once controlled by a handful of manufacturers, the industry has expanded to include tech giants and new entrants eager to capitalize on regulatory changes. At first glance, this shift appears to be a step forward in accessibility. However, the sudden commercialization of hearing aids raises serious concerns about the future of hearing healthcare.
This comment analyzes the hearing aid market before and after OTC legislation. Examining both its benefits and consequences. The influx of corporations—many from outside the healthcare sector—has shifted the focus of hearing care from patient-centered treatment to mass-market consumerism. While innovation is valuable, this shift threatens to deprioritize professional audiological care, leaving individuals with hearing loss to navigate their treatment without expert guidance.
Ultimately, this comment argues that accessibility should not come at the cost of quality hearing healthcare. Furthermore, it argues against commercializing the hearing aid industry and rather focusing on improving access to personalized hearing care services. This comment calls for legal reforms to reinforce access to prescription hearing aids and audiology services, ensuring that hearing loss is treated as a medical condition rather than a mere consumer electronics problem. Without proper oversight, the industry risks moving toward a future where hearing aids are widely available yet fail to provide meaningful solutions for those who need them most.
